Dieusaert Pharma SRL
Dieusaert Pharma reported total assets of €1.41m at the end of the 2025 financial year (annual accounts filed with the NBB on 17 Dec 2025).
By total assets for 2025, Dieusaert Pharma ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dieusaert Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +241 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dieusaert Pharma's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 17 Dec 2025
- Year ended 30 Jun 2024filed on 02 Jan 2025
- Year ended 30 Jun 2023filed on 22 Dec 2023
- Year ended 30 Jun 2022filed on 31 Jan 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
Dieusaert Pharma's financial analysis
- Solvency36.8%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dieusaert Pharma
Dieusaert Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0539.940.996
- VAT number
- BE0539940996
- Peppol
- Registered · 0208:0539940996 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Oct 2013
- Registered office
- 8953 Heuvelland
- Latest accounts
- 2025 · filed on 17 Dec 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dieusaert Pharma (SRL) has been based in Heuvelland since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 68,064 € and equity of 518,356 €; its revenue is not published. Its solvency stands at 36.8%, below the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dieusaert Pharma
Companies in the same business, of comparable size and area, outside its group.
- De Spiegeleere - Discart Retail sale of pharmaceutical products Braine-l'Alleud · balance sheet €1.36m
- Decopharma Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.36m
- Pharmacie de Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Apotheek Muide Retail sale of pharmaceutical products Ghent · balance sheet €1.41m
- Rafar Retail sale of pharmaceutical products Chimay · balance sheet €1.40m
- WLM Pharma Retail sale of pharmaceutical products Jabbeke · balance sheet €1.38m
- EVDW Retail sale of pharmaceutical products Ghent · balance sheet €1.38m
- Geerts Farma Retail sale of pharmaceutical products Vilvoorde · balance sheet €1.38m
Frequently asked questions about Dieusaert Pharma
What is the revenue of Dieusaert Pharma?
Dieusaert Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dieusaert Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0539940996 for Dieusaert Pharma, if the company is VAT-registered. Its company number (CBE) is 0539.940.996.
Where is the registered office of Dieusaert Pharma?
According to the CBE register, the registered office of Dieusaert Pharma is in 8953 Heuvelland.
What is the equity of Dieusaert Pharma?
At the close of the 2025 financial year, the equity of Dieusaert Pharma amounts to 518,356 €, a solvency of 36.8% of total assets.
Who manages Dieusaert Pharma?
The register lists 1 active mandates at Dieusaert Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dieusaert Pharma within its sector?
By total assets for 2025, Dieusaert Pharma ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Dieusaert Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →